EpiPen manufacturer will release generic to help make lifesaving allergy drug more affordable

The manufacturer of the lifesaving allergy drug EpiPen said Monday that it will release a generic version of the medicine for a list price of $300 for two, following widespread criticism after the company, Mylan, dramatically increased the price from $100 for two to as much as $700 since 2007.

The generic form of the drug will be available in both 0.15 and 0.30 mg in strength.

The announcement follows backlash over the steep increase in price, including outrage expressed by Hillary Clinton. Mylan also announced last week a savings card for patients with higher out-of-pocket costs, which, Reuters reported, will cover "up to $300" for a two-pack of epinephrine dispensers and cut costs for a patient paying list price by about 50 percent.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up